We realize COVID-19 has increased your patient backlog and put enormous pressure on your clinic in many ways. As the leader in breast ultrasound AI, we want to get you back up to speed quickly. Identify lesions that are at higher risk and prioritize those patients with our Backlog Risk Assessment. No additional patient visit required.

Koios DS Breast has been clinically proven to accurately and appropriately downgrade up to 40% of BI-RADS 3 cases, while increasing cancer detection up to 6%.